YAFO NEWCO HUB

Building Global Biopharma Assets into Tomorrow's Companies

YAFO NewCo Hub

Building Global Biopharma Assets into Tomorrow's Companies

YAFO has been a licensed fund manager since 2015 and has managed multiple investment funds. Building on its investment expertise and extensive global life sciences network, YAFO invests in innovative biopharmaceutical assets worldwide through the YAFO NewCo Hub. The YAFO NewCo Hub is an integrated strategic partnership, clinical incubation, and transaction platform jointly established by YAFO, industry partners, and investors. The platform identifies high-potential biopharmaceutical assets globally and brings together the capital, expertise, and operational resources required to advance their development. Through the NewCo Hub, YAFO supports assets across key stages of value creation, including strategic partnership formation, R&D financing, pipeline and indication strategy, clinical development, company building, and eventual licensing, M&A, or other strategic transactions. Our goal is to transform promising scientific innovation into clinically validated, commercially attractive, and transaction-ready biopharmaceutical assets. We welcome biopharmaceutical industry partners and investors to connect with us to explore collaboration, incubation, and investment opportunities.

1. Strategic Collaboration

  • Asset evaluation and partnership positioning
  • Establish strategic asset partnerships
  • Secure capital investment

2. Clinical Development and Incubation

  • Clinical trials and regulatory approval
  • Product pipeline strategy
  • China and overseas market coordination

3. Asset Transactions (Licensing/M&A)

  • Asset acquisition by listed companies
  • Out-licensing (regional or global rights)
  • Asset bundling and IPO integration